IBanga le-Pharmaceutical 1256388-51-8 Ledipasvir yoNyango lweHepatitis C

Inkcazelo emfutshane:

Ubunyulu:≧99%, umgubo ongekho-mhlophe

Umgangatho Womgangatho:Endlwini okanye njengoko kufuneka

Isatifikethi:I-COA, i-MOA, i-MSDS, njl

Umthamo:50Kg/ngenyanga

Beka ubomi kwishelufa:iminyaka eyi-2

Isicelo:Iyeza elisetyenziselwa ukunyanga i-hepatitis C

Iqela eliluncedo:Iqela lokuthengisa impahla ngaphandle elinamava kunye noqeqesho lobungcali kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Imvelisoigama	Ledipasvir
Izithethantonye	Ledipasvircomd.kunye ne-acetone
Inombolo yeCAS.	1256388-51-8
Imbonakalo	Umgubo omhlophe ngaphandle
Ifomula yeemolekyuli	C₄₉H₅₄F₂N₈O₆
Ubunzima beMolekyuli	889.00
Ukusetyenziswa	IBanga lezamayeza okanye injongo yoPhando
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo

Ledipasvir Cas: 1441674-54-9
Izinto	Umgangatho	Iziphumo
Imbonakalo	Umgubo omhlophe ngaphandle	Umgubo omhlophe ngaphandle
Ukuchongwa	Isampuli kunye nomgangatho ubonisa okufanayoixesha lokugcina	Iyahambelana
Amanzi	NMT 1.0%	0.20%
I-Enantiomer	NMT 1.0%	ND
Into enxulumeneyo	Ubumdaka bubonke i-NMT 1.0%	0.52%
Ubunyulu	≥99.0%	99.48%
Isiphelo:iyahambelana nemigangatho yangaphakathi.

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf